All Stories

  1. Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms
  2. Biobank linked to SWEDEHEART quality registry—routine blood sample collection opens new opportunities for cardiovascular research
  3. Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study
  4. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  5. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non–ST-Elevation Acute Coronary Syndrome
  6. Stroke: a rare but devastating procedural complication of PCI: Figure 1
  7. Response to the letter to the editor by Ariza-Solé et al
  8. Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry
  9. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial